Trademark Search in Canada

L'AVENIR SE CULTIVE ICI

View On IC.GC.CA

REGISTERED

on 30 Sept 2020

Last Applicant/ Owned by

MEDICAGO INC.

4100-1155 boulevard René-LevesqueMontréal

QUEBEC

H3B3V2

Serial Number

1912729 filed on 1^st Aug 2018

Registration Number

TMA1082582 registered on 30^th Sept 2020

Registration expiry Date

30^th Sept 2030

Correspondent Address

NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.

COMPLEXE JULES-DALLAIRE/TOUR OGILVY RENAULT BUREAU 1500, 2828, BOULEVARD LAURIERQUÉBEC

QUÉBEC

G1V0B9

L'AVENIR SE CULTIVE ICI

Trademark usage description

pharmaceutical and medicinal preparations and substances namely therapeutic proteins and antibodies namely human vaccines, antivirals, anti-inflammato Read More

Classification Information

Class [005]
Pharmaceutical and medicinal preparations and substances namely therapeutic proteins and antibodies namely human vaccines, antivirals, anti-inflammatory, anti-infectives, anti-fungals, human hormones, antineoplastics, anti-cancer, antipsychotics, anti-bacteria, anti-opioids, immunomodulatory agents.

Classification kind code

Class [035]
Operation of a company specializing in the sale of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies.

Classification kind code

Class [040]
Manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies for others; Operation of a company specializing in the custom manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies.

Classification kind code

Class [042]
Research and development in the field of vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; Operation of a company specializing in the development of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates.

Classification kind code

Mark Details

Serial Number

1912729

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 23^rd Sept 2020	Registration Pending
Submitted for opposition 42 on 13^th May 2020	Advertised
Submitted for opposition 26 on 16^th Apr 2020	Approved
Submitted for opposition 27 on 16^th Apr 2020	Approval Notice Sent
Submitted for opposition 15 on 7^th Oct 2019	Correspondence Created
Submitted for opposition 22 on 4^th Feb 2019	Search Recorded
Submitted for opposition 20 on 4^th Feb 2019	Examiner's First Report
Submitted for opposition 31 on 3^rd Aug 2018	Formalized
Submitted for opposition 30 on 1^st Aug 2018	Filed
Submitted for opposition 1 on 1^st Aug 2018	Created

L'AVENIR SE CULTIVE ICI

Classification Information

Classification kind code

Class [035]Operation of a company specializing in the sale of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies.

Classification kind code

Class [040]Manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies for others; Operation of a company specializing in the custom manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies.

Classification kind code

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [035]
Operation of a company specializing in the sale of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies.

Class [040]
Manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies for others; Operation of a company specializing in the custom manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies.